Hummingbird Bioscience

Biotech startup Hummingbird raises extra US$6m in extended Series B funding

SINGAPORE-BASED Hummingbird Bioscience, which is developing antibody drugs for cancer treatment, has raised an additional US$6 million, closing its extended Series B funding round at US$25 million, it...

Startups

Hummingbird targets antibody discovery hurdle in fighting cancer

ANTIBODIES is the buzzword in the race to cure cancer. Naturally produced by our immune systems, they can be used as drugs to bind to target proteins and invoke certain effects, such as destroying can...

Latest T-bills Treasury Bills Results & Interest News Latest SSB Singapore Savings Bonds News Latest COE Certificate of Entitlement News

Latest Johor-Singapore SEZ News Latest BTO Build To Order & Sales of Balance News Latest STI Straits Times Index News Latest SGX Dividends, Share Price News Latest Bonds Market News Latest Singapore Stocks To Buy News Latest Singapore Economy News